Gabapentin for Post-Operative Pain Control and Narcotic Reduction in Scrotal Surgery

• Status: Recruiting
• Trial end date: 2022-12-01
• Target enrollment: 0
• Participant gender: Male

Summary

The use of non-narcotic multi-modal analgesia to be used in the pre-operative, peri-operative and post-operative period to reduce or potentially eliminate narcotic usage following scrotal surgery. Research study results have shown that the use of anti-inflammatories in the peri-operative period reduces both pain and narcotic use. The hypothesis is that adding another agent in the multi-modal pathway will further reduce pain and potentially reduce narcotic usage.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Weill Medical College of Cornell University
• Treatments: Gabapentin; Narcotics

Criteria

Inclusion Criteria:

• Participants undergoing microsurgical testicular sperm extraction.

• Participants over 18 years of age who can provide informed consent

• Participants with no contraindication to the consumption gabapentin or documented allergy/intolerance

• Participants not currently using opiates for another reason

Exclusion Criteria:

• Contraindication to the consumption of celecoxib or gabapentin

• History of substance abuse (including prior opiate abuse)

• Narcotic use within last 3 months

• Any of the following comorbidities: renal failure, heart disease, peptic ulcer disease, cerebrovascular disease, significant liver disease, untreated depression, chronic pain disorder, or bleeding diatheses

• Medical history or concurrent illness that the investigator considers sufficiently serious to interfere with the conduct, completion, or results of this trial, or constitutes an unacceptable risk to the subject